BioCentury
ARTICLE | Company News

Infigen, Novartis deal

January 2, 2001 8:00 AM UTC

Infigen received a $1 million milestone payment from NVS following development of a reproducible nuclear transfer-based cloning program and several litters of cloned pigs. Under a 1999 collaboration, ...